Nisa Investment Advisors LLC grew its stake in MetLife, Inc. (NYSE:MET – Free Report) by 0.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 205,916 shares of the financial services provider’s stock after purchasing an additional 631 shares during the period. Nisa Investment Advisors LLC’s holdings in MetLife were worth $16,860,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the stock. MeadowBrook Investment Advisors LLC boosted its holdings in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the period. Wolff Wiese Magana LLC boosted its stake in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife during the 3rd quarter valued at about $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of MetLife in the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
MetLife Price Performance
MET stock opened at $85.78 on Thursday. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market capitalization of $59.39 billion, a PE ratio of 17.29, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. The business has a 50 day simple moving average of $83.60 and a 200-day simple moving average of $79.78.
MetLife Dividend Announcement
Analyst Upgrades and Downgrades
Several analysts have commented on MET shares. TD Cowen raised their price objective on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Piper Sandler boosted their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Jefferies Financial Group increased their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Finally, Barclays lifted their price objective on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $89.92.
View Our Latest Analysis on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is a buyback in stocks? A comprehensive guide for investors
- Oracle Announces Game-Changing News for the AI Industry
- The 3 Best Blue-Chip Stocks to Buy Now
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Where to Find Earnings Call Transcripts
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.